who owns semaglutide patent Within weeks of the expiry, multiple Indian pharma companies launched their own versions. As a result, prices now range from ₹1290 to ₹4,500+ depending on the format. This is how Indian pharma companies launch low-cost

Some patients stay on their current dose long-term

Then, your healthcare provider will guide you through the process, advising you when to increase your dose and to what dosage

Important safety information: Wegovy (semaglutide) is a prescription-only medication for the management of obesity

However, whether or not you are a candidate for semaglutide treatment will depend on several factors, including your medical history, current medications, and any underlying health conditions

Originally developed for people with type 2 diabetes, clinical studies showed that semaglutide not only improved blood sugar control but also led to significant weight loss

Most patients tolerate treatment very well over time